103 related articles for article (PubMed ID: 38867326)
1. Functional characterization of two DYRK1B variants causative of AOMS3.
Detro-Dassen S; Sternberg A; Lehmann SM; Schwandt K; Düsterhöft S; Becker W
Orphanet J Rare Dis; 2024 Jun; 19(1):233. PubMed ID: 38867326
[TBL] [Abstract][Full Text] [Related]
2. Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.
Ashford AL; Dunkley TP; Cockerill M; Rowlinson RA; Baak LM; Gallo R; Balmanno K; Goodwin LM; Ward RA; Lochhead PA; Guichard S; Hudson K; Cook SJ
Cell Mol Life Sci; 2016 Feb; 73(4):883-900. PubMed ID: 26346493
[TBL] [Abstract][Full Text] [Related]
3. DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.
Abu Jhaisha S; Widowati EW; Kii I; Sonamoto R; Knapp S; Papadopoulos C; Becker W
Sci Rep; 2017 Jul; 7(1):6420. PubMed ID: 28743892
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties.
Leder S; Czajkowska H; Maenz B; De Graaf K; Barthel A; Joost HG; Becker W
Biochem J; 2003 Jun; 372(Pt 3):881-8. PubMed ID: 12633499
[TBL] [Abstract][Full Text] [Related]
5. A form of the metabolic syndrome associated with mutations in DYRK1B.
Keramati AR; Fathzadeh M; Go GW; Singh R; Choi M; Faramarzi S; Mane S; Kasaei M; Sarajzadeh-Fard K; Hwa J; Kidd KK; Babaee Bigi MA; Malekzadeh R; Hosseinian A; Babaei M; Lifton RP; Mani A
N Engl J Med; 2014 May; 370(20):1909-1919. PubMed ID: 24827035
[TBL] [Abstract][Full Text] [Related]
6. Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B.
Papenfuss M; Lützow S; Wilms G; Babendreyer A; Flaßhoff M; Kunick C; Becker W
Sci Rep; 2022 Feb; 12(1):2393. PubMed ID: 35165364
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A.
Widowati EW; Bamberg-Lemper S; Becker W
BMC Res Notes; 2018 May; 11(1):297. PubMed ID: 29764512
[TBL] [Abstract][Full Text] [Related]
8. Two novel variants in DYRK1B causative of AOMS3: expanding the clinical spectrum.
Mendoza-Caamal EC; Barajas-Olmos F; Mirzaeicheshmeh E; Ilizaliturri-Flores I; Aguilar-Salinas CA; Gómez-Velasco DV; Cicerón-Arellano I; Reséndiz-Rodríguez A; Martínez-Hernández A; Contreras-Cubas C; Islas-Andrade S; Zerrweck C; García-Ortiz H; Orozco L
Orphanet J Rare Dis; 2021 Jun; 16(1):291. PubMed ID: 34193236
[TBL] [Abstract][Full Text] [Related]
9. Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone.
Miyata Y; Nishida E
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119081. PubMed ID: 34147560
[TBL] [Abstract][Full Text] [Related]
10. DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B.
Yousefelahiyeh M; Xu J; Alvarado E; Yu Y; Salven D; Nissen RM
PLoS One; 2018; 13(11):e0207779. PubMed ID: 30496304
[TBL] [Abstract][Full Text] [Related]
11. Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity.
Papadopoulos C; Arato K; Lilienthal E; Zerweck J; Schutkowski M; Chatain N; Müller-Newen G; Becker W; de la Luna S
J Biol Chem; 2011 Feb; 286(7):5494-505. PubMed ID: 21127067
[TBL] [Abstract][Full Text] [Related]
12. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.
Chen Y; Wang S; He Z; Sun F; Huang Y; Ni Q; Wang H; Wang Y; Cheng C
Hum Pathol; 2017 Aug; 66():48-58. PubMed ID: 28554575
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication.
Hamilton ST; Hutterer C; Egilmezer E; Steingruber M; Milbradt J; Marschall M; Rawlinson WD
Placenta; 2018 Dec; 72-73():10-19. PubMed ID: 30501876
[TBL] [Abstract][Full Text] [Related]
14. The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
Gao J; Yang X; Yin P; Hu W; Liao H; Miao Z; Pan C; Li N
Int J Oncol; 2012 Apr; 40(4):1203-9. PubMed ID: 22159921
[TBL] [Abstract][Full Text] [Related]
15. DYRK1B variant linked to autosomal dominant metabolic syndrome.
Hickmott J
Clin Genet; 2015 Jan; 87(1):30-1. PubMed ID: 25092113
[No Abstract] [Full Text] [Related]
16. Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.
Coombs TC; Tanega C; Shen M; Wang JL; Auld DS; Gerritz SW; Schoenen FJ; Thomas CJ; Aubé J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3654-61. PubMed ID: 23642479
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis.
Masaki S; Kii I; Sumida Y; Kato-Sumida T; Ogawa Y; Ito N; Nakamura M; Sonamoto R; Kataoka N; Hosoya T; Hagiwara M
Bioorg Med Chem; 2015 Aug; 23(15):4434-4441. PubMed ID: 26145823
[TBL] [Abstract][Full Text] [Related]
18. Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice.
Bhat N; Narayanan A; Fathzadeh M; Kahn M; Zhang D; Goedeke L; Neogi A; Cardone RL; Kibbey RG; Fernandez-Hernando C; Ginsberg HN; Jain D; Shulman GI; Mani A
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34855620
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases.
Leder S; Weber Y; Altafaj X; Estivill X; Joost HG; Becker W
Biochem Biophys Res Commun; 1999 Jan; 254(2):474-9. PubMed ID: 9918863
[TBL] [Abstract][Full Text] [Related]
20. DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway.
Singh R; Dhanyamraju PK; Lauth M
Oncotarget; 2017 Jan; 8(1):833-845. PubMed ID: 27903983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
